Related Experiment Video
Updated: May 14, 2025
06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.1K
Navigating Scientific Progress in Radiation Oncology: Comprehensive Analysis of Clinical Trials From the Past Two
Sebastian M Christ1,2, Maksym Fritsak1,3, Gabriel Kobeissi2
1Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, CH.
JCO Global Oncology
|April 11, 2025
Summary
Radiation oncology clinical trials have grown significantly, with digestive, CNS, and head and neck cancers leading research. Increased global contributions and industry investment are needed to advance novel therapies.
Area of Science:
- Radiation oncology
- Clinical trial analysis
- Cancer research trends
Background:
- Oncology clinical trial activity has surged in recent decades.
- A comprehensive evaluation of radiation oncology research trends is currently lacking.
- This study addresses this gap by analyzing radiation therapy trials.
Purpose of the Study:
- To analyze trends in radiation oncology clinical trials.
- To examine trial activity over time, geographic distribution, and trial phases.
- To identify areas for future research and investment in radiation oncology.
Main Methods:
- Analysis of 4,253 radiation oncology trials from ClinicalTrials.gov.
- Examination of trends in trial activity, geographic distribution, and trial phases.
- Data collected up to February 2024.
Main Results:
- Significant increase in radiation oncology trial activity observed.
- Digestive, CNS, and head and neck cancers represent 49.7% of studies.
- Emergence of oligometastasis research (2.2%), decline in hematology trials (9.7%).
- Phase II trials dominate (51.3%); North America leads (58.2%), with growing European (21.2%) and Asian (25.2%) contributions.
- Low industry funding (6%) indicates financial challenges.
Conclusions:
- Radiation oncology research is dynamic, with evolving trends.
- Need to address regional disparities and promote novel technologies and drug-radiotherapy combinations.
- Emphasis on increasing industry investment for Phase I and III trials is crucial.
Related Concept Videos
01:16Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
01:21Cancer Survival Analysis
308
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
308
01:12Hazard Ratio
71
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
71
01:20Comparing the Survival Analysis of Two or More Groups
92
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
92
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106